Parameterization and validation of a new AMBER force field for an oxovanadium (IV) complex with therapeutic potential implications in Alzheimer's disease
- 4 May 2023
- journal article
- research article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 122, 108511
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 23 references indexed in Scilit:
- Combining classical molecular dynamics and quantum mechanical methods for the description of electronic excitations: The case of carotenoidsJournal of Computational Chemistry, 2016
- Molecular MechanicsCurrent Pharmaceutical Design, 2014
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?British Journal of Clinical Pharmacology, 2011
- Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitusBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Discovery of a New Phosphotyrosine Mimetic for PTP1B Using Breakaway TetheringJournal of the American Chemical Society, 2003
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agentJournal of the American Chemical Society, 1995
- A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic MoleculesJournal of the American Chemical Society, 1995
- A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP modelThe Journal of Physical Chemistry, 1993